CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia

Davide Rossi, Antonella Zucchetto, Francesca Maria Rossi, Daniela Capello, Michaela Cerri, Clara Deambrogi, Stefania Cresta, Silvia Rasi, Lorenzo De Paoli, Chiara Lobetti Bodoni, Pietro Bulian, Giovanni Del Poeta, Marco Ladetto, Valter Gattei, Gianluca Gaidano

Research output: Contribution to journalArticle

Abstract

Identification of prognosticators for Binet A chronic lymphocytic leukemia is important for selecting patients with dismal prognosis. We analyzed CD49d expression in 140 consecutive Binet A chronic lymphocytic leukemia. At diagnosis, CD49d ≥30% (54/140, 38.6%) associated with proliferation markers, namely CD38 ≥30% (p=3.9×10-6), LDH (p=0.007) and β2-microglobulin (p=0.020). Univariate log-rank analysis identified CD49d ≥30% as a risk factor of treatment free survival (p=8.3×10 -5), time to progression to a more advanced stage (p=4.7×10-4), and time to lymphocyte doubling (p=0.009). Multivariate analysis selected CD49d ≥30% as an independent treatment free survival predictor after adjustment for biological (HR 2.28; 95% CI 1.71-4.45, p=0.015) and both biological and clinical variables analyzed together (HR 3.33, 95% CI 1.61-6.90, p=0.001). Within Binet A subgroups harboring favorable biological variables (IGHV homology

Original languageEnglish
Pages (from-to)1575-1579
Number of pages5
JournalHaematologica
Volume93
Issue number10
DOIs
Publication statusPublished - Oct 2008

    Fingerprint

Keywords

  • Binet A
  • CD49d
  • Chronic lymphocytic leukemia
  • Prognostic factor

ASJC Scopus subject areas

  • Hematology

Cite this

Rossi, D., Zucchetto, A., Rossi, F. M., Capello, D., Cerri, M., Deambrogi, C., Cresta, S., Rasi, S., De Paoli, L., Bodoni, C. L., Bulian, P., Poeta, G. D., Ladetto, M., Gattei, V., & Gaidano, G. (2008). CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. Haematologica, 93(10), 1575-1579. https://doi.org/10.3324/haematol.13103